Esperion Therapeutics, Inc. (NASDAQ: ESPR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ESPERION THERAPEUTICS, INC.

Esperion Therapeutics, Inc. (NASDAQ: ESPR)
Listen to this Section


$3.16
+0.0100 ( +0.32% ) 0.6K

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Clinical Trial Pipeline Stages


Drug Name Stage
Nexletol (bempedoic acid)DetailsHeterozygous familial hypercholesterolemia, Atherosclerotic cardiovascular disease , Hypercholesterolemia Approved
Nexlizet (bempedoic acid and ezetimibe)DetailsHypercholesterolemia, Atherosclerotic cardiovascular disease , Heterozygous familial hypercholesterolemia, Cardiovascular risk reduction Approved

Market Data


Open $3.16
Previous Close $3.15
Volume 0.6K
Market Cap $811.73M
Day Range $3.16 - $3.17
52 Week Range $0.95 - $4.18
Shares Outstanding 257.69M
Change % +0.32%
Net Change ▲ 0.0100
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Year2013
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,294,677.00

Date Type Amount Purchased Purchaser
2024-07-19 Sale -917.00 Foody Joanne M.
2024-07-19 Sale -108.00 Warren Eric
2024-06-20 Sale -2540.00 Warren Eric
2024-06-20 Sale -3285.00 Foody Joanne M.
2024-05-24 Sale -65000.00 Woody Tracy M
2024-05-24 Sale -23000.00 Shepard Jay
2024-05-24 Sale -23000.00 CARROLL J MARTIN
2024-05-24 Sale -23000.00 Fuhrman Alan
2024-05-24 Sale -23000.00 GOTTO ANTONIO M JR MD D PHIL
2024-05-24 Sale -23000.00 ROCAMBOLI STEPHEN

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 72 Nov 06, 2025
8-k 8K-related 13 Nov 06, 2025
8-k 8K-related 14 Nov 04, 2025
4 Insider transactions 2 Oct 20, 2025
8-k 8K-related 18 Oct 08, 2025
8-k 8K-related 39 Oct 07, 2025
4 Insider transactions 2 Sep 18, 2025
4 Insider transactions 2 Sep 18, 2025
4 Insider transactions 1 Sep 18, 2025
10-q Quarterly Reports 72 Aug 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy